Joel Baglole

Joel Baglole

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

Alphabet Remains a Solid Investment Despite Recent Issues

Although Covid-19 has caused short-term problems, Alphabet remains a diverse company primed for growth. Here's more about GOOGL stock.

The Top 7 Blue-Chip Stocks for the Rest of 2020

Blue-chip stocks provide investors with stability during volatile periods, offering consistent returns and reliable dividends. Here is a list of seven of the top blue-chip stocks to carry investors through the remainder of 2020.

4 Airline Stocks To Leave On The Runway

Investors should avoid these airline stocks until the global pandemic is behind us and international travel returns to normal levels.

As a Vaccine Looks More Likely, Moderna Stock Still Is a Good Bet

Pharmaceutical company Moderna is at the forefront of the global race to develop a vaccine against Covid-19. We could know as early as October whether Moderna's vaccine will be given the green light from regulators, and the company is already scaling up production to meet demand. Investors would be smart to buy MRNA shares now and ride them higher in the coming months.

7 Growth Stocks to Ride for the Rest of 2020

Investors can count on these growth stocks to deliver consistent, positive returns for the remainder of this year and beyond.